Ascletis Showcases Innovative ASC47 Weight Loss Drug Research at European Congress on Obesity At the 32nd European Congress on Obesity, Ascletis will present findings on ASC47, a unique weight loss drug that aims to preserve muscle while promoting fat loss.

Ascletis Showcases Innovative ASC47 Weight Loss Drug Research at European Congress on Obesity #China #Hong_Kong #ASC47 #Ascletis_Pharma #ECO_2025